Patent delisted for Purdue Pharma drug OXYCONTIN
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one […]
Patent delisted for Purdue Pharma drug OXYCONTIN Read Post »
Patent Expiration
Patent Expiration
Patent Expiration
Patent delisted for Boehringer Ingelheim drug TRADJENTA
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug TRADJENTA Read Post »
Patent Expiration
Patent delisted for Boehringer Ingelheim drug JENTADUETO
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs.
Patent delisted for Boehringer Ingelheim drug JENTADUETO Read Post »
Patent Expiration
Patent delisted for Circassia drug TUDORZA PRESSAIR
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Circassia and is included in one NDA.
Patent delisted for Circassia drug TUDORZA PRESSAIR Read Post »
Patent Expiration
Patent delisted for Boehringer Ingelheim drug JARDIANCE
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Patent Expiration
Patent delisted for Helsinn Hlthcare drug ALOXI
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs.
Patent Expiration
Patent delisted for Daiichi Sankyo drug BENICAR HCT
Annual Drug Patent Expirations for BENICAR+HCT Benicar Hct is a drug marketed by Daiichi Sankyo and is included in one
Patent delisted for Daiichi Sankyo drug BENICAR HCT Read Post »
Patent Expiration
Patent delisted for Astrazeneca Ab drug BYDUREON
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs.
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Patent Expiration
Patent delisted for Astrazeneca Ab drug BYDUREON PEN
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
